This inventor holds 30 USPTO granted patents, plus 1 CIPO patent, primarily in Glucokinase Compounds. Top assignees: Imperial Chemical Industries Limited, Astrazeneca Ab. Active years: 1983-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Poynton, GB (1983 - 1997)
- Cheshire, GB (2007 - 2009)
- Macclesfield, GB (2004 - 2011)
Company Filing History:
Years Active: 1983-2011
Areas of Expertise:
Title: Innovations of Rodney B. Hargreaves in Pharmaceutical Chemistry
Introduction
Rodney B. Hargreaves, an inventive mind based in Poynton, GB, has made significant contributions to pharmaceutical chemistry with a portfolio of 24 patents. His inventive spirit has led to the development of novel compounds that impact various applications, particularly in the field of cardiovascular health.
Latest Patents
Among Hargreaves' latest patents is the invention of aminopyridinium compounds, which are characterized by complex formulas and various functional groups. These novel compounds offer a unique versatility in chemical applications. Additionally, he has developed amino 1,3,5-triazine derivatives designed as agents for the cardiovascular system. These compounds possess beneficial effects, particularly in modulating the function of the sino-atrial node, showcasing Hargreaves' commitment to advancing cardiovascular health through innovative chemistry.
Career Highlights
Hargreaves is currently associated with Imperial Chemical Industries Limited, a prominent player in the chemical industry. His career is marked by a focus on developing new chemical entities that hold therapeutic potential. With each patent, he not only demonstrates his inventiveness but also contributes to the wider body of pharmaceutical knowledge.
Collaborations
Throughout his career, Hargreaves has collaborated with esteemed colleagues, including Bernard J. McLoughlin and Stuart D. Mills. These partnerships have enriched his research endeavors and fostered innovation within the pharmaceutical community.
Conclusion
Rodney B. Hargreaves stands out as a key figure in the sphere of innovations related to cardiovascular pharmaceuticals. With his extensive patent portfolio and impactful collaborations, he continues to drive advancements in therapeutic solutions that benefit public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile